alarum_Logo_Final_ (002).jpg
Alarum to Release Fourth Quarter and Full Year 2023 Earnings on March 14, 2024
February 29, 2024 08:30 ET | Alarum Technologies Ltd.
The Company Will Host a Conference Call on Thursday, March 14, 2024, at 08:30 a.m. Eastern Time Tel Aviv, Israel, Feb. 29, 2024 (GLOBE NEWSWIRE) --  Alarum Technologies Ltd. (Nasdaq, TASE:...
February 28, 2024 16:30 ET | UMH Properties, Inc.
FREEHOLD, NJ, Feb. 28, 2024 (GLOBE NEWSWIRE) -- UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) reported Total Income of $220.9 million for the year ended December 31, 2023 as compared to $195.8 million...
Magic Software to Announce Fourth Quarter and Full year 2023 Financial Results on March 13th, 2024
February 28, 2024 09:37 ET | Magic Software Enterprises Ltd.
Or Yehuda, Israel, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC), a global provider of IT consulting services and end-to-end integration and low-code...
Sofwave Medical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
February 28, 2024 08:00 ET | SofWave Medical, Ltd.
SAN CLEMENTE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (“the Company”) (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices, today announced...
Nayax Logo.jpg
Nayax Reports Record Fourth Quarter and Full Year 2023 Financial Results 
February 28, 2024 07:30 ET | Nayax Ltd.
Nayax Reports Record Q4 and Full Year 2023 Financial Results
Kamada logo.jpg
Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024
February 28, 2024 07:00 ET | Kamada Ltd.
REHOVOT, Israel, and HOBOKEN, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed...
Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals
February 28, 2024 07:00 ET | Pluri Inc.
Growing pipeline of industry-specific new potential products, services, collaborations and partnerships through PluriAgtech, PluriCDMO, PluriHealth, and PluriFoodRecent achievements include: new...
Purple Biotech Presents Data of its Phase 1 Head & Neck Cancer of NT219 in combination with Cetuximab at ESMO TAT Congress 2024
February 27, 2024 07:00 ET | Purple Biotech Ltd.
NT219 was well tolerated Anti-tumor activity at relevant higher dose levels observed with 29% Objective Response Rate (ORR) and 71% Disease Control Rate (DCR) REHOVOT, Israel, Feb. 27, 2024...
Gilat Logo Full Color.png
Gilat Presents Fourth Quarter and Full Year 2023 Results
February 26, 2024 07:06 ET | Gilat Satellite Networks Ltd.
Q4 Revenue of $75.6 million, GAAP Operating Income of $2.9 million and Adjusted EBITDA of $9.4 million 2023 Revenue of $266.1 million, up 11% year over year, GAAP Operating Income of $28.1 million...
Portfolio Overview
Enlight Renewable Energy Reports Fourth Quarter 2023 Financial Results
February 26, 2024 06:00 ET | Enlight Renewable Energy Ltd.
All of the amounts disclosed in this press release are in U.S. dollars unless otherwise noted TEL AVIV, Israel, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Enlight Renewable Energy Ltd. (NASDAQ: ENLT,...